This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initation could lead to fewer recurrent strokes.
Using genetics to understand why disease of the small blood vessels in the brain occurs
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
Postdoctoral Fellow: Dr Ulrike Hammerbeck (TSA PDF 2015-02)
We are delighted to announce that we are now launching our Priority Programme Awards in two areas: haemorrhagic stroke, and the psychological consequences of stroke.
In this project, the aim is to demonstrate that failure of drainage of fluid from the grey and white matter of the brain is a mechanism underlying SVD.
The overall purpose of this research is to make laboratory stroke experiments more reliable and useful for informing how to design human clinical trials with a higher chance of success.
The effect of blood pigments on brain inflammation and survival of nerve cells
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.